chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Sex: M
Vaccine: COVID19
Symptoms: Chills, Feeling abnormal, Pyrexia, Somnolence
Clinical narrative: he woke up he felt very weird/all types of things started happening to him; got into bed and slept for 24 hours straight/woke up and slept for another 48 hours; chills; fever; This spontaneous case was reported by a consumer and describes the occurrence of FEELING ABNORMAL (he woke up he felt very weird/all types of things started happening to him), SOMNOLENCE (got into bed and slept for 24 hours straight/woke up and slept for another 48 hours), CHILLS (chills) and PYREXIA (fever) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   In March 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In March 2021, the patient experienced FEELING ABNORMAL (he woke up he felt very weird/all types of things started happening to him), SOMNOLENCE (got into bed and slept for 24 hours straight/woke up and slept for another 48 hours), CHILLS (chills) and PYREXIA (fever). At the time of the report, FEELING ABNORMAL (he woke up he felt very weird/all types of things started happening to him), SOMNOLENCE (got into bed and slept for 24 hours straight/woke up and slept for another 48 hours), CHILLS (chills) and PYREXIA (fever) outcome was unknown.            It was reported that the patient had same experience and side effects with the second shot. The patient's concomitant medication was not reported. No treatment information was provided.  Action taken with the mRNA-1273 in response to the event is not applicable.   This case was linked to MOD-2021-138766 (Patient Link).
Age: 39.0
Sex: M
Vaccine: COVID19
Symptoms: Inappropriate schedule of product administration
Clinical narrative: Vaccine given outside dosing window; This spontaneous case was reported by an other health care professional and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Vaccine given outside dosing window) in a 39-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form(s). On an unknown date, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Vaccine given outside dosing window). At the time of the report, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Vaccine given outside dosing window) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications were reported.  No laboratory details were  provided.  No treatment medications were reported.  Action taken with mRNA-1273 in response to the events was not applicable.
Age: 48.0
Sex: M
Vaccine: COVID19
Symptoms: Fatigue, Pyrexia
Clinical narrative: feel feverish but no fever; really tired; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (feel feverish but no fever) and FATIGUE (really tired) in a 48-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PYREXIA (feel feverish but no fever) and FATIGUE (really tired). At the time of the report, PYREXIA (feel feverish but no fever) and FATIGUE (really tired) outcome was unknown.        mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) dosing remained unchanged.       No concomitant medications were reported. . Treatment unknown (either acetaminophen or ibuprofen)   This case was linked to MOD-2021-138792 (Patient Link).
Age: 89.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site pain, Vaccination site pruritus
Clinical narrative: Injection site right arm was itched; Injection site right arm was sore; Injection site right arm was red; This spontaneous case was reported by a patient and describes the occurrence of VACCINATION SITE PRURITUS (Injection site right arm was itched), VACCINATION SITE PAIN (Injection site right arm was sore) and VACCINATION SITE ERYTHEMA (Injection site right arm was red) in an 89-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 021B21A and 006C21A) for COVID-19 vaccination.     No Medical History information was reported.   On 08-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to at an unspecified dose. On 08-Apr-2021, the patient experienced VACCINATION SITE PRURITUS (Injection site right arm was itched), VACCINATION SITE PAIN (Injection site right arm was sore) and VACCINATION SITE ERYTHEMA (Injection site right arm was red). At the time of the report, VACCINATION SITE PRURITUS (Injection site right arm was itched), VACCINATION SITE PAIN (Injection site right arm was sore) and VACCINATION SITE ERYTHEMA (Injection site right arm was red) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) and mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.       Concomitant product use was not provided. Treatment information was not provided.   This case was linked to MOD-2021-138694 (Patient Link).
Age: 17.0
Sex: F
Vaccine: COVID19
Symptoms: Product administered to patient of inappropriate age
Clinical narrative: Unauthorized Age Patient Received the First Dose; This spontaneous case was reported by a health care professional and describes the occurrence of PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Unauthorized Age Patient Received the First Dose) in a 17-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 014C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 17-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 17-May-2021, the patient experienced PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Unauthorized Age Patient Received the First Dose). On 17-May-2021, PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Unauthorized Age Patient Received the First Dose) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Treatment and concomitant medicines were not provided.
Age: 61.0
Sex: M
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: Sore arm after first dose; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Sore arm after first dose) in a 61-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 040A21A) for COVID-19 vaccination.     No medical history information provided.  Concomitant products included ROSUVASTATIN CALCIUM (CRESTOR), PREDNISONE and PENTOXIFYLLINE for an unknown indication.    On 06-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Mar-2021, the patient experienced PAIN IN EXTREMITY (Sore arm after first dose). On 10-Mar-2021, PAIN IN EXTREMITY (Sore arm after first dose) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product also included lymphatics.  Patient confirmed that no treatment was provided.   This case was linked to MOD-2021-138804 (Patient Link).
Sex: M
Vaccine: COVID19
Symptoms: Myalgia, Pyrexia
Clinical narrative: Low grade fever; aches; This spontaneous case was reported by a patient family member or friend and describes the occurrence of PYREXIA (Low grade fever) and MYALGIA (aches) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. unknown) for COVID-19 vaccination.     No Medical History information was reported.    On 27-Jan-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) at an unspecified dose. On an unknown date, the patient experienced PYREXIA (Low grade fever) and MYALGIA (aches). At the time of the report, PYREXIA (Low grade fever) and MYALGIA (aches) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.        Concomitant product use  was not  provided  Treatment information was not  provided.   Caller's son received vaccinations the same day as caller 27January2021. Son experienced low grade fever aches. Caller did not wish to provide any additional information.   This case was linked to US-MODERNATX, INC.-MOD-2021-138746, US-MODERNATX, INC.-MOD-2021-138764, US-MODERNATX, INC.-MOD-2021-138805 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-138746:caller case US-MODERNATX, INC.-MOD-2021-138764: US-MODERNATX, INC.-MOD-2021-138805:
Age: 48.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Pyrexia
Clinical narrative: chills; feel feverish but normal temperature; This spontaneous case was reported by a consumer and describes the occurrence of CHILLS (chills) and PYREXIA (feel feverish but normal temperature) in a 48-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 16-May-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 2 dosage form. On 16-May-2021, the patient experienced CHILLS (chills) and PYREXIA (feel feverish but normal temperature). At the time of the report, CHILLS (chills) and PYREXIA (feel feverish but normal temperature) outcome was unknown.            Concomitant medications and treatment medications were not provided.  The patient reports that they experienced chills, feels feverish but have a normal temperature with second dose of Moderna COVID-19 vaccine.   This case was linked to MOD-2021-138786 (Patient Link).
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: Site of inoculation was sore; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (Site of inoculation was sore) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042L20A) for COVID-19 vaccination.     The patient's past medical history included Pregnancy (Patient mentioned that she has given birth vaginally 8 times with no real problems and she had zero miscarriages. She stated that she has 8 healthy children.). Concurrent medical conditions included Drug allergy (Bad reaction Trazodone), High cholesterol since 2005 and Prediabetes since 2010. Concomitant products included ATORVASTATIN for High cholesterol.    On 01-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 01-Feb-2021 at 4:00 PM, the patient experienced VACCINATION SITE PAIN (Site of inoculation was sore). At the time of the report, VACCINATION SITE PAIN (Site of inoculation was sore) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Treatment information was not provided.   This case was linked to MOD-2021-067642 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 06-Jun-2021: Follow up received on 06 JUNE 2021 and does not any new information.
Age: 82.0
Sex: F
Vaccine: COVID19
Symptoms: Rash
Clinical narrative: rash is going up both arms; both hands were covered with rash; rash on left hand; This spontaneous case was reported by a consumer and describes the occurrence of RASH (rash on left hand), RASH (both hands were covered with rash) and RASH (rash is going up both arms) in an 82-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history provided by reporter.  Concomitant products included WARFARIN for an unknown indication.   On 12-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 12-Mar-2021, the patient experienced RASH (rash on left hand). On 15-Apr-2021, the patient experienced RASH (both hands were covered with rash). On an unknown date, the patient experienced RASH (rash is going up both arms). The patient was treated with PREDNISONE at an unspecified dose and frequency. On 15-Mar-2021, RASH (rash on left hand) outcome was unknown. At the time of the report, RASH (both hands were covered with rash) and RASH (rash is going up both arms) outcome was unknown. Not Provided          Action taken with mRNA-1273 was not applicable.   This case was linked to MOD-2021-038535 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 18-May-2021: Follow-up information received on 18-May-2021 and does not contain any new information
Sex: F
Vaccine: COVID19
Symptoms: Nervousness
Clinical narrative: very shakey; This spontaneous case was reported by a consumer and describes the occurrence of NERVOUSNESS (very shakey) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced NERVOUSNESS (very shakey). At the time of the report, NERVOUSNESS (very shakey) outcome was unknown.            Concomitant product use was not provided by the reporter. Treatment information was not provided. Lab details were not provided.  The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) was not applicable.   This case was linked to US-MODERNATX, INC.-MOD-2021-033929 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-033929:1ST DOSE CASE for patient
Age: 78.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Eye irritation, Eye swelling, Feeling abnormal, Lacrimation increased
Clinical narrative: Weepy eyes both; Eye became irritatiing; Swollen eyes; Red eyes; Felt lousy; Felt achy; Chills; Fever; More sore right arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (More sore right arm), EYE SWELLING (Swollen eyes), OCULAR HYPERAEMIA (Red eyes), FEELING ABNORMAL (Felt lousy) and LACRIMATION INCREASED (Weepy eyes both) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 044A21A and 031M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included GERD and Urinary incontinence. Concomitant products included OMEPRAZOLE for GERD, SOLIFENACIN for Urinary incontinence.   On 12-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 16-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 16-Mar-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced PAIN IN EXTREMITY (More sore right arm). On 17-Mar-2021, the patient experienced FEELING ABNORMAL (Felt lousy), VACCINATION SITE PAIN (Felt achy), CHILLS (Chills) and PYREXIA (Fever). On 18-Mar-2021, the patient experienced EYE SWELLING (Swollen eyes), OCULAR HYPERAEMIA (Red eyes), LACRIMATION INCREASED (Weepy eyes both) and EYE IRRITATION (Eye became irritatiing). The patient was treated with PREDNISOLONE at a dose of 1 dosage form. On 18-Mar-2021, FEELING ABNORMAL (Felt lousy), VACCINATION SITE PAIN (Felt achy), CHILLS (Chills) and PYREXIA (Fever) had resolved. On 19-Mar-2021, PAIN IN EXTREMITY (More sore right arm) had resolved. At the time of the report, EYE SWELLING (Swollen eyes), OCULAR HYPERAEMIA (Red eyes), LACRIMATION INCREASED (Weepy eyes both) and EYE IRRITATION (Eye became irritatiing) outcome was unknown.            Action taken with mRNA-1273 in response to the event was not applicable.   This case was linked to US-MODERNATX, INC.-MOD-2021-041177 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-041177:Case for first dose
Age: 78.0
Sex: F
Vaccine: COVID19
Symptoms: Ocular hyperaemia, Pain in extremity, Pyrexia, Vaccination site pain
Clinical narrative: Weepy eyes both; Eye became irritatiing; Swollen eyes; Red eyes; Felt lousy; Felt achy; Chills; Fever; More sore right arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (More sore right arm), EYE SWELLING (Swollen eyes), OCULAR HYPERAEMIA (Red eyes), FEELING ABNORMAL (Felt lousy) and LACRIMATION INCREASED (Weepy eyes both) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 044A21A and 031M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included GERD and Urinary incontinence. Concomitant products included OMEPRAZOLE for GERD, SOLIFENACIN for Urinary incontinence.   On 12-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 16-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 16-Mar-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced PAIN IN EXTREMITY (More sore right arm). On 17-Mar-2021, the patient experienced FEELING ABNORMAL (Felt lousy), VACCINATION SITE PAIN (Felt achy), CHILLS (Chills) and PYREXIA (Fever). On 18-Mar-2021, the patient experienced EYE SWELLING (Swollen eyes), OCULAR HYPERAEMIA (Red eyes), LACRIMATION INCREASED (Weepy eyes both) and EYE IRRITATION (Eye became irritatiing). The patient was treated with PREDNISOLONE at a dose of 1 dosage form. On 18-Mar-2021, FEELING ABNORMAL (Felt lousy), VACCINATION SITE PAIN (Felt achy), CHILLS (Chills) and PYREXIA (Fever) had resolved. On 19-Mar-2021, PAIN IN EXTREMITY (More sore right arm) had resolved. At the time of the report, EYE SWELLING (Swollen eyes), OCULAR HYPERAEMIA (Red eyes), LACRIMATION INCREASED (Weepy eyes both) and EYE IRRITATION (Eye became irritatiing) outcome was unknown.            Action taken with mRNA-1273 in response to the event was not applicable.   This case was linked to US-MODERNATX, INC.-MOD-2021-041177 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-041177:Case for first dose
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Product dose omission issue, SARS-CoV-2 test
Clinical narrative: First vaccination in January 2021 then contracted covid; Had to wait 90 days before they could receive the second dose and now it is past the 90 days; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (First vaccination in January 2021 then contracted covid) and PRODUCT DOSE OMISSION ISSUE (Had to wait 90 days before they could receive the second dose and now it is past the 90 days) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    In January 2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced COVID-19 (First vaccination in January 2021 then contracted covid) and PRODUCT DOSE OMISSION ISSUE (Had to wait 90 days before they could receive the second dose and now it is past the 90 days). At the time of the report, COVID-19 (First vaccination in January 2021 then contracted covid) outcome was unknown and PRODUCT DOSE OMISSION ISSUE (Had to wait 90 days before they could receive the second dose and now it is past the 90 days) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, SARS-CoV-2 test: positive (Positive) Positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant product use was not provided by the reporter. No treatment information was provided.   This case was linked to MOD-2021-138799 (E2B Linked Report).; Sender's Comments:  MOD-2021-138799:Same reporter (wife case)
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Product dose omission issue, SARS-CoV-2 test
Clinical narrative: first vaccination in January 2021 then contracted covid; had to wait 90 days before they could receive the second dose and now it is past the 90 days; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (first vaccination in January 2021 then contracted covid) and PRODUCT DOSE OMISSION ISSUE (had to wait 90 days before they could receive the second dose and now it is past the 90 days) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    In January 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced COVID-19 (first vaccination in January 2021 then contracted covid) and PRODUCT DOSE OMISSION ISSUE (had to wait 90 days before they could receive the second dose and now it is past the 90 days). At the time of the report, COVID-19 (first vaccination in January 2021 then contracted covid) outcome was unknown and PRODUCT DOSE OMISSION ISSUE (had to wait 90 days before they could receive the second dose and now it is past the 90 days) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, SARS-CoV-2 test: positive (Positive) Positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medication information was provided by the reporter. No treatment information was provided.   This case was linked to MOD-2021-138798 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 17-May-2021: Follow up received contains no new information.
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: Weight decreased
Clinical narrative: has lost 25 pounds; This spontaneous case was reported by a consumer and describes the occurrence of WEIGHT DECREASED (has lost 25 pounds) in a 60-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025L20A) for COVID-19 vaccination.     No medical history was provided by the reporter.     On 21-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced WEIGHT DECREASED (has lost 25 pounds). At the time of the report, WEIGHT DECREASED (has lost 25 pounds) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant medication included a fluid pill, which the patient stated that no longer taking since weight loss after first dose.  No treatment information was provided.  Patient stated that her weight loss had nothing to do with vaccine   This case was linked to MODERNATX, INC.-MOD-2021-138150 (E2B Linked Report).   Most recent FOLLOW-UP information incorporated above includes: On 18-Jun-2021: Follow-up received on 18-JUN-2021 and does not contain any new information; Sender's Comments:  MODERNATX, INC.-MOD-2021-138150:crosslinked; husband case
Sex: M
Vaccine: COVID19
Symptoms: Feeling cold, Pain in extremity, Product dose omission issue
Clinical narrative: sore arm; body was cold; haven't got his second shot; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (sore arm), FEELING COLD (body was cold) and PRODUCT DOSE OMISSION ISSUE (haven't got his second shot) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 18-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (sore arm), FEELING COLD (body was cold) and PRODUCT DOSE OMISSION ISSUE (haven't got his second shot). At the time of the report, PAIN IN EXTREMITY (sore arm) and FEELING COLD (body was cold) outcome was unknown and PRODUCT DOSE OMISSION ISSUE (haven't got his second shot) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No relevant concomitant medications were reported. No treatment information was provided.   This case was linked to US-MODERNATX, INC.-MOD-2021-138168, MOD21-091086, MOD21-091084, MOD21-091085 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-138168: MOD21-091086: MOD21-091084: MOD21-091085:
Sex: F
Vaccine: COVID19
Symptoms: Influenza like illness, Peripheral swelling
Clinical narrative: swollen arm; flu like symptoms; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 17-May-2021 and was forwarded to Moderna on 17-May-2021.    This spontaneous case was reported by a consumer and describes the occurrence of PERIPHERAL SWELLING (swollen arm) and INFLUENZA LIKE ILLNESS (flu like symptoms) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 27-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PERIPHERAL SWELLING (swollen arm) and INFLUENZA LIKE ILLNESS (flu like symptoms). At the time of the report, PERIPHERAL SWELLING (swollen arm) and INFLUENZA LIKE ILLNESS (flu like symptoms) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Patient was scared because of swollen arm and flu.  No Concomitant medicines were reported. No Treatment medicines were reported.   This case was linked to US-MODERNATX, INC.-MOD-2021-138746, US-MODERNATX, INC.-MOD-2021-138764, US-MODERNATX, INC.-MOD-2021-138791 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-138746: US-MODERNATX, INC.-MOD-2021-138764: US-MODERNATX, INC.-MOD-2021-138791:
Age: 17.0
Sex: M
Vaccine: COVID19
Symptoms: Product administered to patient of inappropriate age
Clinical narrative: realized 17year old was given the shot in right deltoid; This spontaneous case was reported by a nurse and describes the occurrence of PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (realized 17year old was given the shot in right deltoid) in a 17-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 014C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 17-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 17-May-2021, the patient experienced PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (realized 17year old was given the shot in right deltoid). On 17-May-2021, PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (realized 17year old was given the shot in right deltoid) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant medication was not provided. Treatment information was not provided.
Age: 79.0
Sex: F
Vaccine: COVID19
Symptoms: Libido increased
Clinical narrative: Sexually on fire; This spontaneous case was reported by a consumer and describes the occurrence of LIBIDO INCREASED (Sexually on fire) in a 79-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 019B21A and 022M20A) for COVID-19 vaccination.     No Medical History information was reported.   On 02-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 30-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. In May 2021, the patient experienced LIBIDO INCREASED (Sexually on fire). At the time of the report, LIBIDO INCREASED (Sexually on fire) outcome was unknown.            The concomitant medications were not reported. The treatment information was not provided.   The action taken with mRNA 1273 with the events was considered as not applicable.
Sex: U
Vaccine: COVID19
Symptoms: Inappropriate schedule of product administration
Clinical narrative: more than six weeks between two doses; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 17-May-2021 and was forwarded to Moderna on 17-May-2021.    Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a pharmacist and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (more than six weeks between two doses) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (more than six weeks between two doses). At the time of the report, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (more than six weeks between two doses) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant medication not provided Treatment medication not provided. .; Sender's Comments: This report refers to a case of inappropriate schedule of vaccine administered for mRNA-1273 (lot #unknown) with no associated AEs reported.
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Asthma, Chills, Dizziness, Fatigue
Clinical narrative: swollen face; swollen lips; swollen tongue; asthma attack; feeling like there are boulders on top of her shoulders; feeling weak; dizzy; fatigued; headache; chills; This spontaneous case was reported by a consumer and describes the occurrence of SWELLING FACE (swollen face), LIP SWELLING (swollen lips), SWOLLEN TONGUE (swollen tongue), ASTHMA (asthma attack) and MUSCULOSKELETAL DISCOMFORT (feeling like there are boulders on top of her shoulders) in a 52-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 022B21A) for COVID-19 immunisation. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Asthma and Allergy. Concomitant products included BUDESONIDE (PULMICORT FLEXHALER) for Steroid therapy, SALBUTAMOL SULFATE (VENTOLIN RESPIRATOR) and SALBUTAMOL (ALBUTEROL HFA) for an unknown indication.    On 13-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-May-2021, the patient experienced SWELLING FACE (swollen face), LIP SWELLING (swollen lips), SWOLLEN TONGUE (swollen tongue), MUSCULOSKELETAL DISCOMFORT (feeling like there are boulders on top of her shoulders), ASTHENIA (feeling weak), DIZZINESS (dizzy), FATIGUE (fatigued), HEADACHE (headache) and CHILLS (chills). 14-May-2021, the patient experienced ASTHMA (asthma attack). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) at an unspecified dose and frequency. On 14-May-2021, SWELLING FACE (swollen face), LIP SWELLING (swollen lips) and SWOLLEN TONGUE (swollen tongue) had resolved. At the time of the report, ASTHMA (asthma attack), MUSCULOSKELETAL DISCOMFORT (feeling like there are boulders on top of her shoulders), ASTHENIA (feeling weak), DIZZINESS (dizzy), FATIGUE (fatigued), HEADACHE (headache) and CHILLS (chills) had not resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 14-May-2021, Heart rate: rapid heart beat (abnormal) rapid heart beat. On 14-May-2021, Oxygen saturation: 95 (Inconclusive) 95 %.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment included increased doses of Ventolin and Pulmicort inhalers and Albuterol nebulizer solution.
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Heart rate, Lip swelling, Musculoskeletal discomfort, Oxygen saturation
Clinical narrative: swollen face; swollen lips; swollen tongue; asthma attack; feeling like there are boulders on top of her shoulders; feeling weak; dizzy; fatigued; headache; chills; This spontaneous case was reported by a consumer and describes the occurrence of SWELLING FACE (swollen face), LIP SWELLING (swollen lips), SWOLLEN TONGUE (swollen tongue), ASTHMA (asthma attack) and MUSCULOSKELETAL DISCOMFORT (feeling like there are boulders on top of her shoulders) in a 52-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 022B21A) for COVID-19 immunisation. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Asthma and Allergy. Concomitant products included BUDESONIDE (PULMICORT FLEXHALER) for Steroid therapy, SALBUTAMOL SULFATE (VENTOLIN RESPIRATOR) and SALBUTAMOL (ALBUTEROL HFA) for an unknown indication.    On 13-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-May-2021, the patient experienced SWELLING FACE (swollen face), LIP SWELLING (swollen lips), SWOLLEN TONGUE (swollen tongue), MUSCULOSKELETAL DISCOMFORT (feeling like there are boulders on top of her shoulders), ASTHENIA (feeling weak), DIZZINESS (dizzy), FATIGUE (fatigued), HEADACHE (headache) and CHILLS (chills). 14-May-2021, the patient experienced ASTHMA (asthma attack). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) at an unspecified dose and frequency. On 14-May-2021, SWELLING FACE (swollen face), LIP SWELLING (swollen lips) and SWOLLEN TONGUE (swollen tongue) had resolved. At the time of the report, ASTHMA (asthma attack), MUSCULOSKELETAL DISCOMFORT (feeling like there are boulders on top of her shoulders), ASTHENIA (feeling weak), DIZZINESS (dizzy), FATIGUE (fatigued), HEADACHE (headache) and CHILLS (chills) had not resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 14-May-2021, Heart rate: rapid heart beat (abnormal) rapid heart beat. On 14-May-2021, Oxygen saturation: 95 (Inconclusive) 95 %.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment included increased doses of Ventolin and Pulmicort inhalers and Albuterol nebulizer solution.
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: Swelling face, Swollen tongue
Clinical narrative: swollen face; swollen lips; swollen tongue; asthma attack; feeling like there are boulders on top of her shoulders; feeling weak; dizzy; fatigued; headache; chills; This spontaneous case was reported by a consumer and describes the occurrence of SWELLING FACE (swollen face), LIP SWELLING (swollen lips), SWOLLEN TONGUE (swollen tongue), ASTHMA (asthma attack) and MUSCULOSKELETAL DISCOMFORT (feeling like there are boulders on top of her shoulders) in a 52-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 022B21A) for COVID-19 immunisation. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Asthma and Allergy. Concomitant products included BUDESONIDE (PULMICORT FLEXHALER) for Steroid therapy, SALBUTAMOL SULFATE (VENTOLIN RESPIRATOR) and SALBUTAMOL (ALBUTEROL HFA) for an unknown indication.    On 13-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-May-2021, the patient experienced SWELLING FACE (swollen face), LIP SWELLING (swollen lips), SWOLLEN TONGUE (swollen tongue), MUSCULOSKELETAL DISCOMFORT (feeling like there are boulders on top of her shoulders), ASTHENIA (feeling weak), DIZZINESS (dizzy), FATIGUE (fatigued), HEADACHE (headache) and CHILLS (chills). 14-May-2021, the patient experienced ASTHMA (asthma attack). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) at an unspecified dose and frequency. On 14-May-2021, SWELLING FACE (swollen face), LIP SWELLING (swollen lips) and SWOLLEN TONGUE (swollen tongue) had resolved. At the time of the report, ASTHMA (asthma attack), MUSCULOSKELETAL DISCOMFORT (feeling like there are boulders on top of her shoulders), ASTHENIA (feeling weak), DIZZINESS (dizzy), FATIGUE (fatigued), HEADACHE (headache) and CHILLS (chills) had not resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 14-May-2021, Heart rate: rapid heart beat (abnormal) rapid heart beat. On 14-May-2021, Oxygen saturation: 95 (Inconclusive) 95 %.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment included increased doses of Ventolin and Pulmicort inhalers and Albuterol nebulizer solution.
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Pyrexia, SARS-CoV-2 test
Clinical narrative: low grade fever; tired; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (low grade fever) and FATIGUE (tired) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025b21a) for COVID-19 vaccination.     Concurrent medical conditions included Crohns associated arthritis (Patient takes Toradol injection during Crohn's flare up).    On 02-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In April 2021, the patient experienced PYREXIA (low grade fever) and FATIGUE (tired). At the time of the report, PYREXIA (low grade fever) and FATIGUE (tired) was resolving.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 12-Apr-2021, SARS-CoV-2 test: positive (Positive) COVID-19 Positive, no symptoms just a bit tired. On 13-Apr-2021, SARS-CoV-2 test: positive (Positive) COVID-19 Positive, no symptoms just a bit tired.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were reported. Treatment information was not provided for the first dose events.   This case was linked to MOD-2021-138815 (Patient Link).
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Accidental underdose, Condition aggravated
Clinical narrative: This spontaneous case was reported by a nurse and describes the occurrence of CONDITION AGGRAVATED (Seizure disorder worse since May 30 2021) and ACCIDENTAL UNDERDOSE (nurse administered 0.3 ml amount of vaccine) in a 59-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 003B21A and 003A21A) for COVID-19 vaccination. Concurrent medical conditions included Seizure (Worse since May 30 2021) since 09-Nov-2001, Arthritis (pain in colder weather) since 01-Jan-2001, Depression, Herpes NOS, Stress, Pain and Sulfonamide allergy. Concomitant products included ARIPIPRAZOLE (ABILIFY) from 01-Jan-2021 to an unknown date and ESCITALOPRAM OXALATE from 01-Jan-2021 to an unknown date for Depression, ACICLOVIR (ACYLOVIR) from 01-Jan-2021 to an unknown date for Herpes NOS, METHOCARBAMOL from 01-Jan-2021 to an unknown date for Muscle relaxation, MORPHINE SULFATE from 01-Jan-2021 to an unknown date for Pain, ALPRAZOLAM (XANAX) from 01-Jan-2021 to an unknown date and LAMOTRIGINE (LAMICTAL XR) from 01-Jan-2021 to an unknown date for Seizure. On 14-Apr-2021 at 10:06 AM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .3 milliliter. On 12-May-2021 at 10:03 AM, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 12-May-2021 at 9:00 AM, the patient experienced ACCIDENTAL UNDERDOSE (nurse administered 0.3 ml amount of vaccine). On 30-May-2021, the patient experienced CONDITION AGGRAVATED (Seizure disorder worse since May 30 2021). On 12-May-2021 at 9:00 AM, ACCIDENTAL UNDERDOSE (nurse administered 0.3 ml amount of vaccine) had resolved. At the time of the report, CONDITION AGGRAVATED (Seizure disorder worse since May 30 2021) had not resolved. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. No treatment information was provided by the reporter. Most recent FOLLOW-UP information incorporated above includes: On 30-Jun-2021: Follow-up received updated medical history and concomitant medications , event start/stop dates, patient details. On 28-Jul-2021: Follow-up received, contains non-significant information.
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Illness, Myalgia, Pyrexia
Clinical narrative: really sick; on her back with a 102 temp; joint pain; muscle pain; This spontaneous case was reported by a consumer and describes the occurrence of ILLNESS (really sick), PYREXIA (on her back with a 102 temp), ARTHRALGIA (joint pain) and MYALGIA (muscle pain) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 048b21a and 025b21a) for COVID-19 vaccination.     The patient's past medical history included Crohn's.   On 02-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 30-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 30-Apr-2021, the patient experienced ILLNESS (really sick), PYREXIA (on her back with a 102 temp), ARTHRALGIA (joint pain) and MYALGIA (muscle pain). The patient was treated with IBUPROFEN for Pain, at an unspecified dose and frequency and KETOROLAC TROMETHAMINE (TORADOL) for Fever, at an unspecified dose and frequency. In May 2021, ILLNESS (really sick), PYREXIA (on her back with a 102 temp), ARTHRALGIA (joint pain) and MYALGIA (muscle pain) outcome was unknown.
Age: 16.0
Sex: F
Vaccine: COVID19
Symptoms: Product administered to patient of inappropriate age
Clinical narrative: Somehow a 16 year old was able to slip through the cracks and received a vaccine; This spontaneous case was reported by an other health care professional and describes the occurrence of PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Somehow a 16 year old was able to slip through the cracks and received a vaccine) in a 16-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 19-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Apr-2021, the patient experienced PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Somehow a 16 year old was able to slip through the cracks and received a vaccine). On 19-Apr-2021, PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Somehow a 16 year old was able to slip through the cracks and received a vaccine) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant or treatment medications were reported. The patient did not experience any side effects.
Age: 82.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Received Expired Vaccine (>12 hours in room temperature); This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Received Expired Vaccine (>12 hours in room temperature)) in an 82-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 017C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 14-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-May-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Received Expired Vaccine (>12 hours in room temperature)). On 14-May-2021, EXPIRED PRODUCT ADMINISTERED (Received Expired Vaccine (>12 hours in room temperature)) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Patient did not reported any side effects. No concomitant medications were reported. Treatment information was not provided.    This case was linked to US-MODERNATX, INC.-MOD-2021-138841 (Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-138841:
Age: 40.0
Sex: F
Vaccine: COVID19
Symptoms: Contusion, Dizziness, Erythema, Feeling hot, Headache
Clinical narrative: dizzy; maternal exposure during breast feeding; headache; Bruising; redness; itchiness; warm to the touch; This spontaneous case was reported by a consumer and describes the occurrence of CONTUSION (Bruising), ERYTHEMA (redness), PRURITUS (itchiness), FEELING HOT (warm to the touch) and DIZZINESS (dizzy) in a 41-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 022B21A and 027B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 16-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 14-May-2021, the patient experienced CONTUSION (Bruising), ERYTHEMA (redness), PRURITUS (itchiness), FEELING HOT (warm to the touch), MATERNAL EXPOSURE DURING BREAST FEEDING (maternal exposure during breast feeding) and HEADACHE (headache). On 17-May-2021, the patient experienced DIZZINESS (dizzy). The patient was treated with IBUPROFEN at a dose of 1 dosage form. On 14-May-2021, MATERNAL EXPOSURE DURING BREAST FEEDING (maternal exposure during breast feeding) had resolved. At the time of the report, CONTUSION (Bruising), ERYTHEMA (redness), PRURITUS (itchiness), FEELING HOT (warm to the touch), DIZZINESS (dizzy) and HEADACHE (headache) outcome was unknown.            Action taken with mRNA-1273 in response to the event was not applicable.  No concomitant medications provided.   Most recent FOLLOW-UP information incorporated above includes: On 18-Jun-2021: TCR received on 18-jun-2021 contains Consent declined to Follow-up.